Hyperoxaluria Panel, Primary, Urine with Creatinine
Also known as: Glycolate, DHG
Use
The primary hyperoxalurias (PH) are a group of inherited disorders caused by defects in glyoxylate metabolism, with a combined incidence of about 1:60,000. To date, three primary hyperoxalurias have been described, designated as PH1, PH2, and PH3. All three forms follow an autosomal recessive mode of inheritance, and lead to increased oxalate levels in the body. The typical presentation is with recurring calcium oxalate renal stones. Calcium oxalate can also deposit in various tissues including the kidneys (nephrocalcinosis). End stage renal disease can occur from damage caused by the systemic oxalosis. The age of onset of symptoms ranges from infancy to adulthood; some adults may remain asymptomatic until the sixth decade.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 13751-3
- 25106-6
- 13749-7
- 25105-8
- 2161-8
- 59462-2
Result Turnaround Time
3-10 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
5 mL (1 mL minimum)
Minimum Volume
1 mL
Container
plastic urine container
Collection Instructions
Preferred: 5 mL (1 mL minimum) urine with no preservative collected in a plastic urine container; Acceptable: Urine, acidified with 6N HCL collected in a plastic urine container
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 72 hours |
| Frozen | 30 days |
